4 ms·
The article isn't talking about running clinical trials, it's talking about making GCMS equipment and the like available.
by Alex3917 12y ago
The article isn't talking about running clinical trials, it's talking about making GCMS equipment and the like available.
- refurb 12y agoThat would help stop people from taking things that are adulterated, but I'd be concerned about the toxicity of the pure drugs as well. A great example of what can happen is Fen-Phen, the diet drug that was taken off the market a while back. The drug fenfluramine also activates the 5-HT2B receptor and causes heart valve damage. All of these designer drugs out there could certainly have off-target effects that would never be noticed unless a clinical trial was run (even then maybe not!) or unless enough users have enough problems that it's noticed (MPTP is great example).